Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial

Christoph Schaefers, Cyrus Khandanpour, Mathias Hänel, Miriam Kull, Winfried Alsdorf, Abdulaziz Kamili, Ricardo Kosch, William Krüger, Stephan Bohl, Elias Karl Mai, Christof Scheid, Hermann Einsele, Monika Brüggemann, Anna Suling, Antonia Zapf, Carsten Bokemeyer, Katja Weisel, Lisa Leypoldt · 2026

Read Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial by Christoph Schaefers, Cyrus Khandanpour, Mathias Hänel, Miriam Kull, Winfried Alsdorf, Abdulaziz Kamili, Ricardo Kosch, William Krüger, Stephan Bohl, Elias Karl Mai, Christof Scheid, Hermann Einsele, Monika Brüggemann, Anna Suling, Antonia Zapf, Carsten Bokemeyer, Katja Weisel, Lisa Leypoldt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13602635.txt.

Description

Christoph Schaefers and a large team of co-authors lay out the BELI(E)VE trial for people with multiple myeloma that has come back or stopped responding to care. The 2026 paper covers patients whose cancer carries the t(11;14) change.

The trial tests belantamab mafodotin plus venetoclax, with or without dexamethasone. It is a German, multicenter, open-label phase I and IIa study. A first part finds the best dose, and a second part treats more patients at that dose to check activity. Safety, side effects, and signs of deep remission are tracked, along with tests of tumor cells in blood.

Catalog record

CREATORChristoph Schaefers, Cyrus Khandanpour, Mathias Hänel, Miriam Kull, Winfried Alsdorf, Abdulaziz Kamili, Ricardo Kosch, William Krüger, Stephan Bohl, Elias Karl Mai, Christof Scheid, Hermann Einsele, Monika Brüggemann, Anna Suling, Antonia Zapf, Carsten Bokemeyer, Katja Weisel, Lisa Leypoldt
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13602635

Browse the full library · About the Tower of Babel